Search Results - "Jama, Y H"

Antibacterial effect of plantaricin LP84 on foodborne pathogenic bacteria occurring as contaminants during idli batter fermentation by Jama, Y.H, Varadaraj, M.C

“…Idli, a traditional cereal/legume-based naturally fermented steamed product with soft and spongy texture is highly popular and widely consumed in India. The…”
Get full text

Increased incidence of HLA-DR3+ individuals amongst HER2/neu expressing breast cancer patients by Carmichael, M. G., Peoples, G. E., Benevides, L. C., Gates, J. D., Patil, R., Amin, A., Jama, Y. H., Craig, D., Ponniah, S., Holmes, J. P.

“…Abstract only…”
Get full text

Clinical and immunologic effects of a HER2/ neu (E75) peptide vaccine booster in previously vaccinated breast cancer patients by Holmes, J. P., Amin, A., Storrer, C. E., Smith, A. M., Jama, Y. H., McNeil, A., Craig, D., Ponniah, S., Peoples, G. E.

“…Abstract only 3014 Background: We are conducting clinical trials of the HER2/neu E75-peptide vaccine in clinically disease-free breast cancer (BCa) patients…”
Get full text

Assessment of circulating tumor cell (CTC) patterns among disease-free breast cancer patients vaccinated with a preventive HER2/ neu E75-peptide vaccine by Amin, A., Stojadinovic, A., Holmes, J. P., Storrer, C. E., Smith, A. M., Jama, Y. H., Craig, D., Ponniah, S., Peoples, G. E.

“…Abstract only 3059 Background: The quantity of CTC and post-treatment reduction predict outcome in medically treated metastatic breast cancer patients (BCa);…”
Get full text

Developing a predictive model for disease status in breast cancer patients using Th1 and Th2 serum cytokine profiles by Khoo, S., Kao, T., Dehqanzada, Z. A., Storrer, C. E., Harris, K. A., Jama, Y. H., Shriver, C. D., Ponniah, S., Peoples, G. E.

“…Abstract only 10078 Background: Using the Luminex multiplex assay, we have reported significant correlations between serum levels of MCP-1, eotaxin, and IL-6…”
Get full text

Early results of a phase I clinical trial of an Ii-Key/Her2/ neu MHC class II peptide-based vaccine in breast cancer patients by Mittendorf, E. A., Khoo, S., Storrer, C. E., Harris, K. A., Jama, Y. H., Dehqanzada, Z. A., Murray, J. L., Shriver, C. D., Von Hofe, E., Ponniah, S., Peoples, G. E.

“…Abstract only 2532 Background: HER2/neu is over-expressed in breast cancer (BCa) and is the source of immunogenic peptides currently being evaluated in…”
Get full text

Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex registered technology by Dehqanzada, Z A, Storrer, CE, Hueman, M T, Foley, R J, Harris, KA, Jama, Y H, Shriver, C D, Ponniah, S, Peoples, GE

“…We used the Luminex assay to compare serum cytokine profiles of breast cancer patients (BCa) to healthy controls, node-positive (NP) patients to node-negative…”
Get full text

Correlations between Serum Monocyte Chemotactic Protein-1 Levels, Clinical Prognostic Factors, and HER-2/neu Vaccine-Related Immunity in Breast Cancer Patients by DEHQANZADA, Zia A, STORRER, Catherine E, HUEMAN, Matthew T, FOLEY, Rebecca J, HARRIS, Katie A, JAMA, Yusuf H, KAO, Tzu-Cheg, SHRIVER, Craig D, PONNIAH, Sathibalan, PEOPLES, George E

“…Purpose: We studied serum monocyte chemotactic protein-1 (MCP-1) levels in breast cancer patients in relationship to their clinicopathologic variables and…”
Get full text